High prevalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia

Journal of Pediatric Gastroenterology and Nutrition

Volumn 62, Issue 5, 2016, Pages 704-710

  Gutiérrez Junquera, Carolina ^a   Fernández Fernández, Sonia ^b   Cilleruelo, M Luz ^a   Rayo, Ana ^b   Echeverría, Luis ^b   Quevedo, Sergio ^b   Bracamonte, Teresa ^b   Román, Enriqueta ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

eosinophilic esophagitis; proton pump inhibitor; proton pump inhibitor responsive esophageal eosinophilia

Indexed keywords

ESOMEPRAZOLE; FLUTICASONE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; DYSPHAGIA; EGG ALLERGY; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL EOSINOPHILIA; ESOPHAGEAL PH MONITORING; ESOPHAGUS DISEASE; ESOPHAGUS PH; FOLLOW UP; FOOD ALLERGY; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MILK ALLERGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORAX PAIN; CHILD; CLINICAL TRIAL; DRUG ADMINISTRATION; ESOPHAGOSCOPY; FEMALE; MALE; PATHOLOGY; PRESCHOOL CHILD; PREVALENCE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DEGLUTITION DISORDERS; DRUG ADMINISTRATION SCHEDULE; EOSINOPHILIC ESOPHAGITIS; ESOMEPRAZOLE; ESOPHAGOSCOPY; FEMALE; HUMANS; INFANT; MALE; PREVALENCE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 84945551223     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001019     Document Type: Article

References (32)

1. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20
2. Soon IS, Butzner JD, Kaplan GG, et al. Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr 2013; 57: 72-80
3. Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are no specific for eosinophilic esophagitis in adults. Am J Gastroenterol 2008; 103: 435-42
4. Ngo P, Furuta GT, Antonioli DA, et al. Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006; 101: 1666-70
5. Sayej WN, Patel R, Baker RD, et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009; 49: 393-9
6. Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2010; 55: 1313-9
7. Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011; 9: 110-7
8. Moawad FJ, Veerappan GR, Dias JA, et al. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol 2013; 108: 366-72
9. Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, et al. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther 2013; 38: 1312-9
10. Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013; 108: 1854-60
11. Moawad FJ, Schoepfer AM, Safroneeva E, et al. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Aliment Pharmacol Ther 2014; 39: 603-8
12. Papadopoulou A, Koletzko S, Heuschkel R, et al. Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr 2014; 58: 107-18
13. Dranove JE, Horn DS, Davis MA, et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr 2009; 154: 96-100
14. Schroeder S, Capocelli KE, Masterson JC, et al. Effect of proton pump inhibitor on esophageal eosinophilia. J Pediatr Gastroenterol Nutr 2013; 56: 166-72
15. Dohil R, Newbury RO, Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci 2012; 57: 1413-9
16. Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis. Validation of a novel classification and grading system. Gut 2013; 62: 489-95
17. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49: 498-547
18. WarnersMJ, van RhijnBD, CurversWL, et al. PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs. Eur J Gastroenterol Hepatol 2015; 27: 506-11
19. Francis DL, Foxx-Orenstein A, Arora AS, et al. Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis. Aliment Pharmacol Ther 2012; 35: 300-7
20. Dalby K, Gaardskaer R, Kruse-Andersen S, et al. Gastroeophageal reflux disease and eosinophilic esophagitis in infants and children. A study of esophageal pH, multiple intraluminal impedance and endocopic ultrasound. Scand J Gastroenterol 2010; 45: 1029-35
21. Dellon ES, Speck O, Woodward K, et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol 2014; 12: 2015-22
22. Wen T, Stucke EM, Grotjan TM, et al. Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology 2013; 145: 1289-99
23. Wen T, Dellon ES, Moawad FJ, et al. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol 2015; 135: 187-97
24. van Rhijn BD, Weijenborg PW, Verheij J, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014; 12: 1815-23
25. Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2013; 62: 824-32
26. Molina-Infante J, Rivas MD, Hernández-Alonso M, et al. Proton pump inhibitors-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and TH2 cytokines overexpression. Aliment Pharmacol Ther 2014; 40: 955-65
27. Molina-Infante J, Katzka DA, Dellon ES. Proton pump inhibitor-responsive esophageal eosinophilia: a historical perspective on a novel and evolving entity. Rev Esp Enferm Dig 2015; 107: 29-36
28. Cheng E. Translating new developments in eosinophilic esophagitis pathogenesis into clinical practice. Curr Treat Options Gastroenterol 2015; 13: 30-46
29. Molina-Infante J, Martinek J, Mart'nez-Alcalá C, et al. Long term efficacy of PPI therapy in patients with PPI-responsive esophageal eosinophilia: an international multicenter study. Gastroenterology 2014; 146(suppl 1): S-393
30. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131: 1381-91
31. Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139: 418-29
32. Spergel JM, Brown-Whitehorn TF, Beausoleil JL. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48: 30-6